Trial
NCT06107829
Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Stephen Ruedrich
Collaborators
Neurocrine Biosciences
Condition
Tardive Dyskinesia
Intervention
Valbenazine Oral Capsule
Why stopped
Not funded
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-24